M. Pritchard
Papers
1
Total Citations
89
H-Index
1
About
M. Pritchard’s research bridges microbiology and biopolymer chemistry, with a focus on developing novel antimicrobial strategies against drug-resistant pathogens. Their most cited work demonstrates that alginate oligosaccharides (OligoG), derived from seaweed, can inhibit fungal cell growth and potentiate the activity of conventional antifungals against clinically important species like *Candida* and *Aspergillus*. This 2014 study, with 89 citations, revealed that OligoG not only disrupts fungal membranes but also enhances the efficacy of existing drugs—a critical advance in an era of rising antifungal resistance. Beyond this flagship paper, Pritchard has contributed to understanding how these oligosaccharides combat bacterial biofilms and synergize with antibiotics against multi-drug resistant bacteria. Their work has significant translational potential, offering a natural, biocompatible platform for combination therapies. By demonstrating that a seaweed-derived compound can both directly inhibit pathogens and restore the potency of failing drugs, Pritchard has opened new avenues for tackling some of the most stubborn infections in clinical settings.
Research Focus
Key Achievements
Top Papers
- 1